Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > REGULATORY
REGULATORY
- 3 Generics with 2 APIs Found to Be Non-Compliant in FY2011 Quality Assurance Project: MHLW
September 4, 2012
- PAFSC’s 1st Committee Recommends Approval for Bayer Yakuhin’s AMD Drug
September 3, 2012
- JPWA, NPhA Confirm Further Efforts Needed to Increase Awareness among Members Amid Lag in Distribution Improvements
September 3, 2012
- MHLW to Seek Funds to Enhance Regulatory Consultation under FY2013 “Priority Budget Scheme”
September 3, 2012
- 1,220 Reports of Adverse Events Associated with OTC Drugs Including 24 Deaths Reported in 5 Years: MHLW
August 31, 2012
- DPJ Submits Bill to Form Third-Party Monitoring Organization for Pharmaceutical Affairs
August 30, 2012
- MHLW to Include Creation of Drug Discovery Support Network in FY2013 Draft Budget Request
August 30, 2012
- MHLW Adds Six APIs/10 Products Including Tenelia to NHI Price List
August 29, 2012
- PMDA Eyes World’s First Approval for New Drugs: Chief Executive Kondo
August 28, 2012
- Drug-Dispensing Expenditure Rises 7.9% to 6,513.3 Billion Yen in FY2011: MHLW
August 28, 2012
- PAFSC 2nd Committee to Review 5 Products Including Novartis’s COPD Drug on Sept. 6
August 24, 2012
- Domestic Pharmaceutical Production Up 3.1 %, to Record high 6,987.4 Bil. Yen in 2011
August 24, 2012
- Two Healthcare Provider Reps at CSIMC Criticize Marketing of a Single Drug under Different Brand Names as “Undesirable”
August 24, 2012
- CSIMC Expert Subcommittee Favors Single Index for Efficacy Assessment of Medical Technology
August 24, 2012
- Drug Pricing Subcommittee Presents Negative Views on Reference Pricing System; “Concerns over Patient Copayment Increases”
August 24, 2012
- MHLW to Recommend Use of ReQuip CR Tablets
August 23, 2012
- CSIMC Approves Listing for 6 APIs/10 Products; Peak Sales Projected at 45.6 Billion Yen for Tenelia
August 23, 2012
- Nonpartisan League of Diet Members Aims to Submit Bill during Current Diet Session to Promote Measures against Strokes
August 23, 2012
- Introduction of RMPs Will Enable Clearer Strategies for Post-Marketing Safety: Ms Tawaragi of PFSB
August 23, 2012
- MHLW Budget Request to Focus on Life Innovation: Minister Komiyama
August 22, 2012
ページ
Japan’s pharmaceutical industry is undergoing a structural shift in its workforce, with the role of sales reps shrinking while production…
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…